Arrowhead Pharmaceuticals Net Income 2006-2019 | ARWR

Arrowhead Pharmaceuticals annual/quarterly net income history and growth rate from 2006 to 2019. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
  • Arrowhead Pharmaceuticals net income for the quarter ending September 30, 2019 was $0.012B, a 208.77% decline year-over-year.
  • Arrowhead Pharmaceuticals net income for the twelve months ending September 30, 2019 was $0.068B, a 224.84% decline year-over-year.
  • Arrowhead Pharmaceuticals annual net income for 2019 was $0.068B, a 224.84% decline from 2018.
  • Arrowhead Pharmaceuticals annual net income for 2018 was $-0.054B, a 58.38% increase from 2017.
  • Arrowhead Pharmaceuticals annual net income for 2017 was $-0.034B, a 57.93% decline from 2016.
Arrowhead Pharmaceuticals Annual Net Income
(Millions of US $)
2019 $68
2018 $-54
2017 $-34
2016 $-82
2015 $-92
2014 $-59
2013 $-31
2012 $-21
2011 $-3
2010 $-6
2009 $-19
2008 $-27
2007 $-30
2006 $-19
2005 $-7
Arrowhead Pharmaceuticals Quarterly Net Income
(Millions of US $)
Q4 2019 $12
Q3 2019 $20
Q2 2019 $24
Q1 2018 $12
Q4 2018 $-11
Q3 2018 $-16
Q2 2018 $-15
Q1 2017 $-13
Q4 2017 $-11
Q3 2017 $-6
Q2 2017 $-6
Q1 2016 $-12
Q4 2016 $-22
Q3 2016 $-19
Q2 2016 $-21
Q1 2015 $-19
Q4 2015 $-25
Q3 2015 $-16
Q2 2015 $-29
Q1 2014 $-23
Q4 2014 $-22
Q3 2014 $-12
Q2 2014 $-14
Q1 2013 $-11
Q4 2013 $-14
Q3 2013 $-6
Q2 2013 $-7
Q1 2012 $-5
Q4 2012 $-5
Q3 2012 $-8
Q2 2012 $-5
Q1 2011 $-2
Q4 2011 $-3
Q3 2011 $-2
Q2 2011 $3
Q1 2010 $-1
Q4 2010 $-2
Q3 2010 $-0
Q2 2010 $-2
Q1 2009 $-2
Q4 2009 $-3
Q3 2009 $-3
Q2 2009 $-5
Q1 2008 $-8
Q4 2008 $-9
Q3 2008 $-8
Q2 2008 $-6
Q1 2007 $-5
Q4 2007 $-8
Q3 2007 $-12
Q2 2007 $-6
Q1 2006 $-4
Q4 2006 $-7
Q3 2006 $-4
Q2 2006 $-5
Q1 2005 $-3
Q4 2005 $-3
Q3 2005 $-3
Q2 2005 $1
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $6.486B $0.169B
Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company which develops novel drugs to treat intractable diseases primarily in the United States. The company's proprietary Dynamic Polyconjugate platform develops drugs based on the RNA interference mechanism which silences disease-causing genes. Its products include ARC-520, ARC-521, ARC-AAT, ARC-F12, ARC-HIF2 and ARC-LPA which are in different clinical trial phase. Arrowhead Pharmaceuticals, Inc., formerly known as Arrowhead Research Corporation, is headquartered in Pasadena, California.
Stock Name Country Market Cap PE Ratio
Takeda Pharmaceutical (TAK) Japan $62.499B 9.88
Zoetis (ZTS) United States $57.742B 34.54
Astellas Pharma (ALPMY) Japan $32.535B 16.25
Eisai (ESALY) Japan $21.712B 41.87
UCB SA (UCBJF) Belgium $15.658B 0.00
Grifols, S.A (GRFS) Spain $15.559B 20.39
Merck (MKGAF) Germany $14.630B 19.97
Neurocrine Biosciences (NBIX) United States $10.476B 494.57
Ono Pharmaceutical (OPHLF) Japan $9.450B 20.20
Ionis Pharmaceuticals (IONS) United States $8.896B 18.02
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $8.638B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $8.562B 10.94
Catalent (CTLT) United States $7.617B 30.99
IPSEN SA ADR (IPSEY) France $7.404B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.263B 0.00
Orion OYJ (ORINY) Finland $5.849B 30.12
STADA ARZNEIMI (STDAF) Germany $5.375B 0.00
Hypermarcas (HYPMY) Brazil $4.849B 17.43
FibroGen (FGEN) United States $4.167B 122.46
Nektar Therapeutics (NKTR) United States $4.066B 0.00
United Therapeutics (UTHR) United States $3.995B 0.00
Taro Pharmaceutical Industries (TARO) Israel $3.733B 13.64
Evotec AG (EVTCY) Germany $3.406B 55.73
Sage Therapeutics (SAGE) United States $3.247B 0.00
PTC Therapeutics (PTCT) United States $2.972B 0.00
ArQule (ARQL) United States $2.379B 0.00
Xencor (XNCR) United States $2.350B 71.43
Heron Therapeutics (HRTX) United States $2.307B 0.00
Portola Pharmaceuticals (PTLA) United States $2.198B 0.00
Zogenix (ZGNX) United States $2.072B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.934B 61.65
Tilray (TLRY) Canada $1.930B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.901B 56.24
ChemoCentryx (CCXI) United States $1.720B 0.00
USANA Health Sciences (USNA) United States $1.645B 17.55
Corcept Therapeutics (CORT) United States $1.571B 19.10
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.488B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.257B 28.70
CLINIGEN GP (CLIGF) United Kingdom $1.245B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.198B 0.00
Spectrum Pharmaceuticals (SPPI) United States $1.162B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.065B 7.27
Endo (ENDP) Ireland $1.041B 1.91
Radius Health (RDUS) United States $1.034B 0.00
Karyopharm Therapeutics (KPTI) United States $0.998B 0.00
Aerie Pharmaceuticals (AERI) United States $0.975B 0.00
Flexion Therapeutics (FLXN) United States $0.770B 0.00
Akebia Therapeutics (AKBA) United States $0.707B 0.00
Collegium Pharmaceutical (COLL) United States $0.703B 0.00
TherapeuticsMD (TXMD) United States $0.656B 0.00
ImmunoGen (IMGN) United States $0.569B 0.00
Translate Bio (TBIO) United States $0.521B 0.00
Dermira (DERM) United States $0.496B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.493B 0.00
Organogenesis Holdings (ORGO) United States $0.469B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.464B 56.25
Molecular Templates (MTEM) United States $0.462B 0.00
Ardelyx (ARDX) United States $0.449B 0.00
Harpoon Therapeutics (HARP) United States $0.439B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.437B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.423B 18.23
Indivior (INVVY) United States $0.399B 1.44
BioCryst Pharmaceuticals (BCRX) United States $0.387B 0.00
Recro Pharma (REPH) United States $0.387B 0.00
Lannett Co Inc (LCI) United States $0.370B 4.31
DURECT (DRRX) United States $0.367B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.362B 0.00
OptiNose (OPTN) United States $0.359B 0.00
Innate Pharma SA (IPHYF) France $0.358B 0.00
Siga Technologies (SIGA) United States $0.353B 8.07
Concordia (CXRXF) Canada $0.322B 0.00
Rafael Holdings (RFL) United States $0.319B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.316B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.298B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.275B 0.00
KalVista Pharmaceuticals (KALV) United States $0.272B 0.00
Jounce Therapeutics (JNCE) United States $0.270B 3.61
GlycoMimetics (GLYC) United States $0.261B 0.00
Calithera Biosciences (CALA) United States $0.247B 0.00
Xeris Pharmaceuticals (XERS) United States $0.239B 0.00
Ocular Therapeutix (OCUL) United States $0.194B 0.00
Aquestive Therapeutics (AQST) United States $0.194B 0.00
Concert Pharmaceuticals (CNCE) United States $0.188B 0.00
Nature's Sunshine Products (NATR) United States $0.187B 32.23
Foamix Pharmaceuticals (FOMX) Israel $0.182B 0.00
Taiwan Liposome (TLC) Taiwan $0.167B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.150B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.145B 0.00
IMV INC (IMV) Canada $0.143B 0.00
MEI Pharma (MEIP) United States $0.141B 0.00
Redhill Biopharma (RDHL) Israel $0.138B 0.00
CannTrust Holdings (CTST) Canada $0.129B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.126B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
CV Sciences (CVSI) United States $0.091B 0.00
Champions Oncology (CSBR) United States $0.091B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.088B 0.00
MediWound (MDWD) Israel $0.083B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.079B 23.68
Capnia (SLNO) United States $0.079B 0.00
Otonomy (OTIC) United States $0.078B 0.00
Neos Therapeutics (NEOS) United States $0.075B 0.00
Aclaris Therapeutics (ACRS) United States $0.074B 0.00
PolarityTE (PTE) United States $0.074B 0.00
Infinity Pharmaceuticals (INFI) United States $0.072B 0.00
Cardiome Pharma (CORV) Canada $0.071B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.067B 0.00
Pharmaxis (PXSLY) Australia $0.065B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.064B 0.00
RENEURON GP (RNUGF) United Kingdom $0.062B 0.00
Nivalis Therapeutics (ALPN) United States $0.060B 0.00
Novan (NOVN) United States $0.060B 0.00
AgeX Therapeutics (AGE) United States $0.058B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.057B 0.00
Genocea Biosciences (GNCA) United States $0.056B 0.00
SCYNEXIS (SCYX) United States $0.056B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.056B 0.00
Iterum Therapeutics (ITRM) Ireland $0.056B 0.00
Natural Alternatives (NAII) United States $0.055B 13.80
Medicure (MCUJF) Canada $0.055B 0.00
ElectroCore (ECOR) United States $0.052B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.051B 0.00
CTI BioPharma (CTIC) United States $0.051B 0.00
IntelGenx Technologies (IGXT) Canada $0.051B 0.00
Mast Therapeutics (SVRA) United States $0.048B 0.00
IsoRay (ISR) United States $0.046B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.040B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.040B 0.00
Forward Pharma (FWP) Denmark $0.038B 0.00
Opexa Therapeutics (ACER) United States $0.038B 0.00
Mannatechorporated (MTEX) United States $0.038B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.033B 0.00
India Globalization Capital (IGC) United States $0.029B 0.00
PharmAthene (ALT) United States $0.028B 0.00
Jaguar Animal Health (JAGX) United States $0.028B 0.00
Shineco (TYHT) China $0.028B 0.00
Biomerica (BMRA) United States $0.028B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.026B 0.00
Melinta Therapeutics (MLNT) United States $0.023B 0.00
ProPhase Labs (PRPH) United States $0.023B 0.00
Bio-Path Holdings (BPTH) United States $0.022B 0.00
China SXT Pharmaceuticals (SXTC) China $0.020B 0.00
Heat Biologics (HTBX) United States $0.016B 0.00
Flex Pharma (SLRX) United States $0.016B 0.00
Regulus Therapeutics (RGLS) United States $0.016B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.016B 0.00
VAXART, INC (VXRT) United States $0.016B 0.00
Vical (BBI) United States $0.015B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.014B 0.00
Cyanotech (CYAN) United States $0.013B 0.00
Lipocine (LPCN) United States $0.010B 0.00
Achieve Life Sciences (ACHV) United States $0.009B 0.00
HANCOCK JAFFE (HJLI) United States $0.008B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.007B 0.00
RXi Pharmaceuticals (PHIO) United States $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Can-Fite Biopharma (CANF) Israel $0.005B 0.00
Hemispherx BioPharma (AIM) United States $0.003B 0.00
Onconova Therapeutics (ONTX) United States $0.002B 0.00
Midatech Pharma (MTP) United Kingdom $0.002B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.001B 0.00
Advanced Accelerator Applications S.A (AAAP) France $0.000B 0.00